Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trial

Modupe Idowu, Lucas Otieno, Bogdan Dumitriu, Clarisse L. C. Lobo, Swee Lay Thein, Biree Andemariam, Obiageli Nnodu, Adlette Inati, Alexander Glaros, Pablo Bartolucci, Raffaella Colombatti, Alì Taher, Miguel R. Abboud, Deepika S. Darbari, Kenneth I. Ataga, Bülent Antmen, Kevin H.M. Kuo, Samuel de Souza Medina, Abdulafeez Oluyadi, Varsha Iyer, Susan Morris, Amber M. Yates, Hui Shao, Spurthi Patil, Rolandas Urbstonaitis, Ahmar U. Zaidi, Sarah Gheuens, Wally R. Smith